MedTrace Logo

Global Controlled Trial on Effects of an Online Self-Help Program for of Ambitious Altruists on Their Mental Health, Wellbeing, and Productivity: Comparing Versions With IFS vs. CBT, Buddy- vs. Group-, Standard- vs. Minimum-Guidance Intensity.

NCT06442072 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-06-04

No results posted yet for this study

Summary

This study aims to compare different versions of a 16-week online self-help program in terms of their effect on self-assessed mental health, well-being, and productivity. The versions differ in their intensity (standard, low) and type (buddy, group) of guidance, the applied psychotherapeutic approaches taught (IFS, CBT). We expect to recruit a sample of \~150 ambitious altruists and have them self-select into the four program versions. Participants take part in surveys before, at weeks 8, 12, and 16 to self-assess their productivity, mental health burden, quality of life, and other risk and protection factors. Weekly screenings will provide data on objective and subjective success components such as participant engagement, working alliance, and treatment adherence, which will be correlated with primary and secondary outcomes.

Conditions

  • Treatment Adherence and Compliance
  • Anxiety
  • Depression
  • Mental Health Issue
  • Quality of Life
  • Well-Being, Psychological
  • Social Functioning
  • Cognitive Dysfunction
  • Interpersonal Relations
  • Self Esteem
  • Loneliness
  • Functioning, Psychosocial
  • Functioning, Social

Interventions

BEHAVIORAL

guided online self-help program

16 weeks of training and application of psychotherapeutic methods

Sponsors & Collaborators

  • Maastricht University

    collaborator OTHER

  • Rethink Wellbeing

    lead OTHER

Principal Investigators

  • Inga Grossmann, PhD. · Rethink Wellbeing

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-10
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06442072 on ClinicalTrials.gov